Vault-13

M28 Capital Management LP

STAMFORD, CT · CIK 1807489 · 13F filing filed 2022-08-12

Exempt reporting adviser since 2026 · limited partnership

As an employer

$89.2m reported value -18.0% vs Q1 2022
13positions
96.5%in top 10
0 new 1 added 3 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 8,282,204 $26.9m30.17% 30.17% AddedShares held: Q3 2021 —, Q4 2021 3.8m, Q1 2022 5.8m, Q2 2022 8.3m +2.4m +2,432,204 41.6%
2 INVIVYD INC COM IVVD IVVD 6,398,250 $21.0m23.53% 23.53% UnchangedShares held: Q3 2021 —, Q4 2021 5.7m, Q1 2022 6.4m, Q2 2022 6.4m
3 ROCKET PHARMACEUTICALS INC COM RCKT RCKT 715,880 $9.9m11.04% 11.04% UnchangedShares held: Q3 2021 —, Q4 2021 495.3k, Q1 2022 715.9k, Q2 2022 715.9k
4 STOKE THERAPEUTICS INC COM STOK STOK 527,150 $7.0m7.81% 7.81% UnchangedShares held: Q3 2021 —, Q4 2021 527.1k, Q1 2022 527.1k, Q2 2022 527.1k
5 BRIDGEBIO PHARMA INC COM BBIO BBIO 466,200 $4.2m4.75% 4.75% UnchangedShares held: Q3 2021 —, Q4 2021 466.2k, Q1 2022 466.2k, Q2 2022 466.2k
6 CURIS INC COM NEW COM NEW 4,243,293 $4.2m4.68% 4.68% UnchangedShares held: Q3 2021 —, Q4 2021 2.6m, Q1 2022 4.2m, Q2 2022 4.2m
7 MIRATI THERAPEUTICS INC COM MRTX MRTX 61,200 $4.1m4.61% 4.61% ReducedShares held: Q3 2021 —, Q4 2021 19.2k, Q1 2022 82.9k, Q2 2022 61.2k -21.7k -21,700 -26.2%
8 TG THERAPEUTICS INC COM TGTX TGTX 726,200 $3.1m3.46% 3.46% ReducedShares held: Q3 2021 —, Q4 2021 527.0k, Q1 2022 1.0m, Q2 2022 726.2k -321.7k -321,700 -30.7%
9 LEAP THERAPEUTICS INC COM LPTX LPTX 2,664,400 $3.1m3.43% 3.43% UnchangedShares held: Q3 2021 —, Q4 2021 1.0m, Q1 2022 2.7m, Q2 2022 2.7m
10 VERVE THERAPEUTICS INC COM COM 178,500 $2.7m3.06% 3.06% UnchangedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 178.5k, Q2 2022 178.5k
11 ATARA BIOTHERAPEUTICS INC COM COM 269,253 $2.1m2.35% 2.35% ReducedShares held: Q3 2021 —, Q4 2021 456.9k, Q1 2022 389.4k, Q2 2022 269.3k -120.1k -120,100 -30.9%
12 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,001,800 $779.0k0.87% 0.87% UnchangedShares held: Q3 2021 —, Q4 2021 0, Q1 2022 1.0m, Q2 2022 1.0m
13 NEXIMMUNE INC COM COM 133,442 $215.0k0.24% 0.24% UnchangedShares held: Q3 2021 —, Q4 2021 133.4k, Q1 2022 133.4k, Q2 2022 133.4k